• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Danaher Corporation. (12/5/17). "Press Release: Danaher Announces Quarterly Dividend". Washington, DC.

	Organisation	Danaher Corporation (NYSE: DHR)
	Group	Danaher (Group)
	Product	laboratory equipment and instruments
	Product 2	LIFE SCIENCES
	Person	Gugino, Matthew E. (Danaher 201407 VP Investor Relations)

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on January 26, 2018 to holders of record on December 29, 2017.


ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of over 62,000 associates is united by a common culture and operating system, the Danaher Business System. For more information, please visit www.danaher.com.


For further information: Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860

Record changed: 2018-01-16

Advertisement

More documents for Danaher (Group)

• [1] LGC. (11/25/20). "Press Release: LGC Offers Regulated Bioanalysis on the Sciex TripleTOF 6600 High-Resolution Mass Spectrometry Platform". London....
• [2] Beckman Coulter Life Sciences. (11/12/20). "Press Release: Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs". Indianapolis, IN....
• [3] AB Sciex (d/b/a Sciex). (4/1/20). "Press Release: Sciex Debuts Breakthrough Method for Gene Therapies". Framingham, MA....
• [4] Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC....
• [5] Cepheid. (21/3/20). "Press Release: Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test". Sunnyvale, CA....
• [6] AB Sciex (d/b/a Sciex). (3/19/20). "Press Release: Sciex Statement on the Effects of COVID-19"....
• [7] Cepheid. (2/28/20). "Press Release: Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology". Sunnyvale, CA & Cambridge, MA....
• [8] Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA....
• [9] Sartorius AG. (10/21/19). "Press Release: Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses". Göttingen....
• [10] Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.